ストックスクリーナーアプリを入手
16.36
1.18%
0.19
アフターアワーズ：
16.37
0.01
+0.06%
前日終値:
$16.17
開ける：
$16
24時間の取引高:
73,759
Relative Volume:
1.47
時価総額：
$429.46M
収益：
$59,000
当期純損益:
$-21.81M
株価収益率:
-1.4938
EPS:
-10.9518
ネットキャッシュフロー:
$-18.07M
1週間 パフォーマンス:
-0.97%
1か月 パフォーマンス:
+16.61%
6か月 パフォーマンス:
+20.38%
1年 パフォーマンス:
+55.66%
1日の値動き範囲:
$16.00
$16.68
1週間の範囲:
$15.20
$16.76
52週間の値動き範囲:
$9.10
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
BNTC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
16.36 | 424.47M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-07 | 開始されました | TD Cowen | Buy |
| 2024-12-16 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-13 | 開始されました | Robert W. Baird | Outperform |
| 2024-10-16 | 開始されました | Oppenheimer | Outperform |
| 2024-09-12 | 開始されました | Guggenheim | Buy |
| 2024-07-22 | 開始されました | Leerink Partners | Outperform |
| 2024-06-13 | 開始されました | Piper Sandler | Overweight |
| 2020-10-05 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | 開始されました | Ladenburg Thalmann | Buy |
| 2016-02-26 | ダウングレード | Maxim Group | Buy → Hold |
| 2015-12-31 | 繰り返されました | Maxim Group | Buy |
| 2015-09-16 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Benitec Biopharma Inc (BNTC) 最新ニュース
Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy - The Manila Times
Benitec Biopharma (NASDAQ: BNTC) to Share BB-301 OPMD Study Update in Investor Webcast - Stock Titan
Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy - GlobeNewswire Inc.
Can Benitec Biopharma Inc. rally from current levelsEarnings Recap Report & AI Forecast Swing Trade Picks - newser.com
Benitec Biopharma Inc. recovery potential after sell offBond Market & Stepwise Entry/Exit Trade Alerts - newser.com
Chart based analysis of Benitec Biopharma Inc. trends2025 Institutional Moves & AI Powered Market Trend Analysis - newser.com
Strategies to average down on Benitec Biopharma Inc.2025 Major Catalysts & Fast Gain Swing Trade Alerts - newser.com
Is Benitec Biopharma Inc. stock attractive for long term wealth buildingJuly 2025 Catalysts & Scalable Portfolio Growth Ideas - newser.com
Custom strategy builders for tracking Benitec Biopharma Inc.Weekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com
Will HYGH stock return to pre crash levels2025 Volatility Report & Fast Exit and Entry Trade Guides - newser.com
Is Benitec Biopharma Inc. stock positioned well for digital economyJuly 2025 Retail & Accurate Trade Setup Notifications - newser.com
Using economic indicators to assess Benitec Biopharma Inc. potentialGDP Growth & Verified High Yield Trade Plans - newser.com
Benitec Biopharma Inc. stock trendline breakdownQuarterly Profit Review & Real-Time Buy Signal Notifications - newser.com
Real time social sentiment graph for Benitec Biopharma Inc.Portfolio Profit Report & Growth Oriented Trade Recommendations - newser.com
What sentiment indicators say about Benitec Biopharma Inc. stockJuly 2025 Trends & High Conviction Trade Alerts - newser.com
Why Benitec Biopharma Inc. stock is popular among millennials2025 Top Gainers & Precise Entry and Exit Recommendations - fcp.pa.gov.br
Using AI based signals to follow Benitec Biopharma Inc.Weekly Trend Summary & Community Consensus Stock Picks - newser.com
Benitec Biopharma Inc (BNTC) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):